Skip to content
Open access

Case Report: Multimodal treatment of pediatric H3G34-mutant diffuse hemispheric glioma: a safety and feasibility case report combining precision medicine and tumor treating fields with conventional care

Nov 2026 · Frontiers in Oncology · 0 citations · 66 references

TL;DR

A case of a 13-year-old boy with H3G34-DHG who underwent a multimodal treatment strategy, combining backbone chemotherapy, radiotherapy, surgery, tumour treating fields with Wilms Tumour-1 (WT1) directed dendritic cell immunotherapy and targeted therapy (STAT3-inhibition) supports the feasibility of combining multiple therapeutic modalities in the management of high-risk paediatric brain tumours.

Abstract

Diffuse hemispheric glioma, H3G34-mutant (H3G34-DHG) is a rare, highly malignant brain tumour with a dismal prognosis and a median time to progression (TTP) of 10 months with best available practice. We report a case of a 13-year-old boy with H3G34-DHG who underwent a multimodal treatment strategy, combining backbone chemotherapy, radiotherapy, surgery, tumour treating fields with Wilms Tumour-1 (WT1) directed dendritic cell immunotherapy and targeted therapy (STAT3-inhibition). The patient had a TTP of 787 days or 25 months, more than double the literature-reported median, with preserved quality of life and showing downregulation of WT1. This case supports the feasibility of combining multiple therapeutic modalities in the management of high-risk paediatric brain tumours, with potential synergy between different treatment elements. While access to novel therapies in the context of clinical trials remains essential, this case illustrates how treatment can be tailored to individual tumour biology and tolerability. The rationale presented in this detailed case report can inform future trial designs and promote precision medicine approaches for this tumour type.

Read PDF

Similar papers

Open access Oct 2026

Multifocal Glioblastoma Managed With Primary Temozolomide as a Strategy to Delay Radiation Therapy: Clinical and Radiological Outcomes.

AIM To evaluate the clinical and radiological outcomes of upfront temozolomide (TMZ) monotherapy in deferring radiotherapy for multifocal glioblastoma (GBM). METHODS We analysed 18 consecutive adult patients with newly diagnosed, multifocal GBM treated with upfront TMZ monotherapy between 2016 and 2024. The primary e...

Chun Khai Loh, H. Wheeler, Adrian Lee et al. · 0 citations
Review Open access Oct 2026

Radiographic progression patterns and treatment response in adult H3 K27-altered diffuse midline glioma: a descriptive review and single center case series

Heterogeneity of adult H3 K27-altered DMG is highlighted and patterns of adult H3 K27-altered DMG in cases assessed at autopsy are described in cases assessed at autopsy.

A. Lahrache, H. Reecher, Aleksandra Winiarz et al. · 0 citations
Case report Open access Sep 2026

Stage IIIB pulmonary sarcomatoid carcinoma treated with spatially fractionated radiotherapy combined with antiangiogenic therapy and sequential chemo-immunotherapy: A case report

Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non-small-cell lung cancer, characterized by high invasiveness and treatment resistance. Patients with PSC often exhibit poor treatment outcomes, short median survival and a dismal prognosis, necessitating novel comprehensive treatment strategies to address thi...

Zi-Jian Qiu, F. Xuan, Xi-Lan Mao et al. · 0 citations
Review Sep 2026

Abstract C015: Clinicogenomic characterization of diffuse hemispheric glioma presenting pre-operatively with tumor-associated bleeding

Clinogenomic characterization of diffuse hemispheric glioma presenting pre-operatively with tumor-associated bleeding suggests survival, transcriptional, and mutational differences for pediatric DHG patients presenting with tumor-associated bleeding are suggested.

N. Joshi, Patrick J. Beck, Rakesh A. Murugesan et al. · 0 citations
Open access Oct 2026

Multimodal Combination Treatment in a Patient-Centered Approach is Associated with Improved Outcome in Relapsed/Refractory Sarcomas in Children: A Comparative Single-Institution Real-World Analysis.

INTRODUCTION Targeted treatment in children, especially with sarcomas, has limited utility due to small numbers of patients with driving mutations. Multimodal combination treatment and patient-centered approach combine treatment modalities administered based on comprehensive biological and empirical factors. Together,...

M. Kyr, K. Polaskova, P. Múdry et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.